Captopril

A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.

297 PubMed studies analyzed · 14 RCTs · Evidence Score: 43.6

Research Domains

Captopril has been studied across 14 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🫁 Liver & Detox, 🔥 Metabolic, ✨ Skin & Hair. The primary research focus is ❤️ Cardiovascular with 57% of studies addressing this area.

Loading evidence profile...

This evidence profile for Captopril is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.